P. Nair

发表

EGFR targeting monoclonal antibody combines with an mTOR inhibitor and potentiates tumor inhibition by acting on complementary signaling hubs

R. James, Siddharth Vishwakarma, I. Chivukula, 2012, Cancer medicine.

Corrigendum to “Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progression” [Gynecol. Oncol. 104 (2007) 352–361]

P. Nair, G. Mukherjee, Michael Rehman, 2007 .

Increased angiogenesis in the uterine cervix associated with human papillomavirus infection.

M. Nair, P. Nair, M. Pillai, 1999, Pathology, research and practice.

Cellular manifestations of human papillomavirus infection in the oral mucosa

M. Nair, P. Nair, M. Pillai, 1999, Journal of surgical oncology.

Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications

P. Nair, N. Chirmule, Anshu Kuriakose, 2016, Journal of immunology research.

Analytical similarity assessment of MYL-1402O to reference Bevacizumab

R. Melarkode, P. Nair, Laxmi Adhikari, 2021, Expert opinion on biological therapy.

Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression.

P. Nair, G. Mukherjee, Michael Rehman, 2007, Gynecologic oncology.

Predicting the Severity of Disease Progression in COVID-19 at the Individual and Population Level: A Mathematical Model

P. Nair, N. Chirmule, V. Nerurkar, 2021, Clinical & experimental pharmacology.

Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

M. S. Ramakrishnan, N. Pandey, E. Montero, 2014, Journal of the American Academy of Dermatology.

Telomerase, p53 and Human Papillomavirus Infection in the Uterine Cervix

P. Nair, 2000, Acta oncologica.

T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab

R. Melarkode, E. Montero, P. Nair, 2017, PloS one.

Epidermal growth factor receptor family and its role in cancer progression

P. Nair, Pradip Nair, 2005 .

Papillomavirus-Mediated Neoplastic Progression Is Associated with Reciprocal Changes in Jagged1 and Manic Fringe Expression Linked to Notch Activation

M. Stanley, R. Kumar, P. Nair, 2004, Journal of Virology.

Activated Notch1 Inhibits p53-Induced Apoptosis and Sustains Transformation by Human Papillomavirus Type 16 E6 and E7 Oncogenes through a PI3K-PKB/Akt-Dependent Pathway

K. Somasundaram, P. Nair, S. Krishna, 2003, Journal of Virology.

Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFR

Chetana Basavaraj, R. Melarkode, P. Nair, 2010, Cancer biology & therapy.

CD6 synergistic co‐stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction

R. Melarkode, E. Montero, P. Nair, 2010, Clinical and experimental immunology.

Safety, Efficacy and pharmacokinetics of T1h, a humanized anti-CD6 monoclonal antibody, in moderate to severe chronic plaque psoriasis - Results from a randomized phase II trial.

R. Melarkode, P. Nair, H. Iyer, 2010 .

Predicting the severity of disease progression in COVID-19 at the individual and population level: A mathematical model

P. Nair, N. Chirmule, V. Nerurkar, 2021, medRxiv.

BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth

P. Nair, Chaitali Dey, A. Suresh, 2023, Cancer research.

Multiple sclerosis (PP-038)

D. Arnold, F. Najafi, A. Bar-Or, 2010 .

Spontaneous programmed cell death in infiltrating duct carcinoma: association with p53, BCL-2, hormone receptors and tumor proliferation.

M. Nair, P. Nair, J. Madhavan, 1998, Pathology, research and practice.